Connect Has A Best-In-Class Anti-IL-13 In Eczema, But Won’t Be Taking On Apogee Yet

 
• By Andrew McConaghie
  
Both companies were presenting results at the ADD meeting at the Colorado Convention Center in Denver.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Start-Ups & SMEs

More from Business